11778 Federal Register / Vol. 86, No. 37 / Friday, February 26, 2021 / Notices 

Atlanta, Georgia 30329–4027, telephone 

(404) 498–2741; NAnderson@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: This Committee is charged 

with providing scientific and technical 

advice and guidance to the Secretary, 

HHS; the Assistant Secretary for Health; 

the Director, CDC; the Commissioner, 

Food and Drug Administration (FDA); 

and the Administrator, Centers for 

Medicare and Medicaid Services (CMS). 

The advice and guidance pertain to 

general issues related to improvement in 

clinical laboratory quality and 

laboratory medicine practice and 

specific questions related to possible 

revision of the Clinical Laboratory 

Improvement Amendments of 1988 

(CLIA) standards. Examples include 

providing guidance on studies designed 

to improve safety, effectiveness, 

efficiency, timeliness, equity, and 

patient-centeredness of laboratory 

services; revisions to the standards 

under which clinical laboratories are 

regulated; the impact of proposed 

revisions to the standards on medical 

and laboratory practice; and the 

modification of the standards and 

provision of non-regulatory guidelines 

to accommodate technological 

advances, such as new test methods, the 

electronic transmission of laboratory 

information, and mechanisms to 

improve the integration of public health 

and clinical laboratory practices. 

Matters To Be Considered: The agenda 

will include agency updates from CDC, 

CMS, and FDA. In addition to the 

agency updates, presentations will 

include an update on CLIAC 

recommendations and an overview of 

the Laboratory Response Network. The 

focus of the meeting is a continuation of 

the fall 2020 theme, Clinical Laboratory 

Medicine in the Age of COVID–19 and 

will include presentations and 

discussions on clinical laboratory 

perspectives on laboratory-developed 

tests; application of CLIA regulations 

during the COVID–19 pandemic; and 

the expansion of point-of-care and athome collection and testing. Agenda 

items are subject to change as priorities 

dictate. 

It is the policy of CLIAC to accept 

written public comments and provide a 

brief period for oral public comments 

pertinent to agenda items. Public 

comment periods for each agenda item 

are scheduled immediately prior to the 

Committee discussion period for that 

item. In general, each individual or 

group requesting to present an oral 

comment will be limited to a total time 

of five minutes (unless otherwise 

indicated). Speakers should email 

CLIAC@cdc.gov or notify the contact 

person at least five business days prior 

to the meeting date. For individuals or 

groups unable to attend the meeting, 

CLIAC accepts written comments until 

the date of the meeting (unless 

otherwise stated). However, it is 

requested that comments be submitted 

at least five business days prior to the 

meeting date so that the comments may 

be made available to the Committee for 

their consideration and public 

distribution. All written comments will 

be included in the meeting Summary 

Report posted on the CLIAC website. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–04041 Filed 2–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC, announces the following meeting 

of the Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board). This meeting is open to the 

public, limited only by the space 

available. There are 200 spaces for the 

audio conference and computer lines 

combined. The public is welcome to 

submit written comments in advance of 

the meeting, to the contact person 

below. Written comments received in 

advance of the meeting will be included 

in the official record of the meeting. The 

public is also welcome to listen to the 

meeting by joining a teleconference line 

and/or computer connection 

(information below). 

DATES: The meeting will be held on 

April 14, 2021, from 1:00 p.m. to 6:15 

p.m., EDT and April 15, 2021, from 1:00 

p.m. to 6:15 p.m., EDT. A public 

comment session will be held on April 

14, 2021 at 5:15 p.m. and will conclude 

at 6:15 p.m. or following the final call 

for public comment, whichever comes 

first. Written comments must be 

received on or before April 7, 2021. 

ADDRESSES: You may submit comments 

by mail to: Sherri Diana, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS C– 

34, Cincinnati, Ohio 45226. 

Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 

5252 US (San Jose); +1 646 828 7666 US 

(New York); +1 551 285 1373 US; +1 

669 216 1590 US (San Jose); The 

Meeting ID is: 160 961 6536 and the 

Passcode is: 48605170; Web conference 

by Zoom meeting connection: https://

cdc.zoomgov.com/j/1609616536?pwd=

eUZGYkhONGJn

MzVwWmcvSkNaNmowZz09. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone 

(513) 533–6800, Toll Free 1(800)CDC– 

INFO, Email ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The Advisory Board’s charter was 

issued on August 3, 2001, renewed at 

appropriate intervals, rechartered on 

March 22, 2020, and will terminate on 

March 22, 2022. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 37 / Friday, February 26, 2021 / Notices 11779 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy facility 

who were exposed to radiation but for 

whom it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: NIOSH Program Update; 

Department of Labor Program Update; 

Department of Energy Program Update; 

SEC Petitions Update; Updates on dose 

reconstruction reviews, dose 

reconstruction procedure reviews, 

Savannah River Site SEC Petition #103 

(Aiken, South Carolina; October 1972– 

2007), Metals and Controls Corp. SEC 

Petition #236 (Attleboro, Massachusetts; 

1968–1997), and a Board Work Session. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–03960 Filed 2–25–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10398] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by March 29, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at: https://

www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Generic 

Clearance for Medicaid and CHIP State 

Plan, Waiver, and Program Submissions; 

Use: State Medicaid and CHIP agencies 

are responsible for developing 

submissions to CMS, including state 

plan amendments and requests for 

waivers and program demonstrations. 

States use templates when they are 

available and submit the forms to 

review for consistency with statutory 

and regulatory requirements (or in the 

case of waivers and demonstrations 

whether the proposal is likely to 

promote the objectives of the Medicaid 

program). If the requirements are met, 

we approve the states’ submissions 

giving them the authority to implement 

the flexibilities. For a state to receive 

Medicaid Title XIX funding, there must 

be an approved Title XIX state plan. 

The development of streamlined 

submissions forms enhances the 

collaboration and partnership between 

states and CMS by documenting our 

policy for states to use as they are 

developing program changes. 

Streamlined forms improve efficiency of 

administration by creating a common 

and user-friendly understanding of the 

information we need to quickly process 

requests for state plan amendments, 

waivers, and demonstration, as well as 

ongoing reporting. Form Number: CMS– 

10398 (OMB control number: 0938– 

1148); Frequency: Collection-specific, 

but generally the frequency is yearly, 

once, and occasionally; Affected Public: 

State, Local, or Tribal Governments; 

Number of Respondents: 56; Total 

Responses: 1,540; Total Hours: 154,104 

(3-year total). (For policy questions 

regarding this collection contact 

Annette Pearson at 410–786–6858.) 

Dated: February 23, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–04052 Filed 2–25–21; 8:45 am] 

BILLING CODE 4120–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES